相关实验视频

Updated: Sep 19, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.6K

在黑色素瘤中透瘤的淋巴细胞治疗的外科考虑:随机第三期试验的结果

Liselotte Tas1, Marie B Weitemeyer2, Maartje W Rohaan3,4

  • 1Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

The British journal of surgery
|June 6, 2025
PubMed
概括

在转移性黑色素瘤患者的瘤透性淋巴细胞 (TIL) 治疗中进行的手术切除具有较低的并发症率. 淋巴结转移产生了最高的TIL制造成功率和治疗反应率.

更多相关视频

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

20.3K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.8K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675